Drug Chatter -- Tracking biopharma stock chatter

💊 Get Daily Updates on Generic Entry, Litigation, Biosimilars, and More…

Profile for Applied Genetic Technologies Corporation (AGTC)

« Back to company index

AGTC Chatter Timeline

Stock Ticker for AGTC

Most Active Tweeters for AGTC

UserTweets
@AGTC_ 12
@TigerWTrader1 11
@unbiastock 11
@WALLSTREETODDS_ 7
@kevinjaybe 6

Recent Tweets for AGTC

newsfilterio @newsfilterio
Applied Genetic's XLRP Gene Therapy Shows Improved, Durable Response In Retinal Sensitivity $AGTC https://t.co/AGNbiqgXQA
May 8th 2021, 11:05am
Tickeron @Tickeron
$AGTC in Downtrend: 50-day Moving Average broke below 200-day Moving Average on April 29, 2021. View odds for this… https://t.co/X53bOdczYW
May 8th 2021, 8:05am
eddiedipiero @eddiedipiero
RT @AGTC_: #ICYMI, $AGTC presented additional positive data from the ongoing X-linked retinitis pigmentosa (XLRP) Phase 1/2 clinical trial.…
May 7th 2021, 9:05pm
ShortAlgoTrades @ShortAlgoTrades
$AGTC Stock Rating Updated to Strong Buy: Applied Genetic Technologies Corp. Link to review >>… https://t.co/7bxm03UuKp
May 7th 2021, 6:05pm
AGTC_ @AGTC_
#ICYMI, $AGTC presented additional positive data from the ongoing X-linked retinitis pigmentosa (XLRP) Phase 1/2 cl… https://t.co/Tu7BCOEs2K
May 7th 2021, 4:05pm
ResearchPool @ResearchPool
$AGTC #APPLIED GENETIC TECHNOLOGIES AGTC Sees a Best-in-Class Therapy for XLRP: [...] https://t.co/g65gkFCrah… https://t.co/qomnqRu9BV
May 7th 2021, 2:05am
Raiderman324 @Raiderman324
RT @AGTC_: $AGTC is pleased to announce data from our ongoing XLRP Phase 1/2 clinical trial shows statistically significant improvements in…
May 6th 2021, 11:05pm
MarcJacksonLA @MarcJacksonLA
$AGTC X-linked retinitis pigmentosa Phase 1/2 clinical trial provides positive 12-month data https://t.co/FHhxYVHdET via @OphthTimes
May 6th 2021, 9:05pm
TigerWTrader1 @TigerWTrader1
Bought more $AGTC $3.65.
May 6th 2021, 7:05pm
StockNewsNow @StockNewsNow
$AGTC AGTC Reports Positive 12-Month Data from Highest Dose Groups in its Ongoing XLRP Phase 1/2 Clinical Trial https://t.co/ABJ3rKGWmp
May 6th 2021, 7:05pm
AGTC_ @AGTC_
$AGTC is excited to be featured in an article by @OphthTimes, highlighting Dr. Paul Yang’s presentation of 6-month… https://t.co/mHNhZsoRb6
May 6th 2021, 6:05pm
WALLSTREETODDS_ @WALLSTREETODDS_
$AGTC Out of the 558 other times AGTC was down 4.0% during a trading day, 57% of the time it traded higher by the… https://t.co/bW6nnBNW71
May 6th 2021, 5:05pm
AGTC_ @AGTC_
$AGTC is pleased to announce data from our ongoing XLRP Phase 1/2 clinical trial shows statistically significant im… https://t.co/sSczfEdUE1
May 6th 2021, 3:05pm
SmallCapsDaily @SmallCapsDaily
$AGTC AGTC Reports Positive 12-Month Data from Highest Dose Groups in its Ongoing XLRP Phase 1/2 Clinical Trial Glo… https://t.co/xiBZ5frUdE
May 6th 2021, 2:05pm
MarcJacksonLA @MarcJacksonLA
$AGTC AGTC Reports Positive 12-Month Data from Highest Dose Groups in its Ongoing XLRP Phase 1/2 Clinical Trial https://t.co/NpJytjxipG
May 6th 2021, 1:05pm
GreenSk68859859 @GreenSk68859859
RT @AGTC_: $AGTC’s Clarity Clinical Trials are studying investigational gene therapies to evaluate safety and to determine if they can impr…
May 6th 2021, 1:05pm
StockTexts @StockTexts
$AGTC Applied Genetic Technologies Corporation SEC Filing: Form 8-K https://t.co/OcxGRWP8Dw
May 6th 2021, 1:05pm
EdgarInsider @EdgarInsider
Alert [Press/News Current Report] / Form 8-K filed with the SEC $AGTC APPLIED GENETIC TECHNOLOGIES CORP https://t.co/YofUvFMqF1
May 6th 2021, 1:05pm
StckPro @StckPro
$AGTC NEW ARTICLE : Applied Genetic's XLRP Gene Therapy Shows Improved, Durable Response In Retinal Sensitivity… https://t.co/3qMQ1NCXUn
May 6th 2021, 1:05pm
Briefingcom @Briefingcom
$AGTC: Applied Genetic Technologies reports "positive" 12-month data from highest dose groups in its ongoing XLRP... https://t.co/26LpvgvyqT
May 6th 2021, 1:05pm
OxAnalyst @OxAnalyst
Analyst: How much of a dose-response is there vs. responses due to differences in baseline criteria? $AGTC CSO: No… https://t.co/rNBEmZ7O3p
May 6th 2021, 12:05pm
jeffpaleymd @jeffpaleymd
$agtc---some striking responses in the 12 month and 24 month data with improvements in visual acuity between 6 and… https://t.co/WDYwyv0S5X
May 6th 2021, 12:05pm
OxAnalyst @OxAnalyst
$AGTC Ph1/2 XLRP updated data (last reported Nov 2020) includes two highest dose groups 5 & 6: -Ph 2/3 XLRP 6-mo i… https://t.co/4ZREqi6L3W
May 6th 2021, 12:05pm
RetinaInt @RetinaInt
RT @AGTC_: We’re excited to share that $AGTC partner, @RetinaInt, will present two posters at #ARVO2021 about the Cost of Illness of #IRD a…
May 6th 2021, 12:05pm
sbwcws @sbwcws
Applied Genetic reports data from the ongoing XLRP phase 1/2 clinical trial $AGTC
May 6th 2021, 12:05pm
sbwcws @sbwcws
Applied Genetic to host business news update conference call $AGTC
May 6th 2021, 12:05pm
AGTC_ @AGTC_
$AGTC’s Clarity Clinical Trials are studying investigational gene therapies to evaluate safety and to determine if… https://t.co/KYc9FHUjl6
May 6th 2021, 12:05pm
TeamofStockTra @TeamofStockTra
$AGTC- AGTC Reports Positive 12-Month Data from Highest Dose Groups in its Ongoing XLRP Phase 1/2 Clinical Trial.
May 6th 2021, 11:05am
otcdynamics @otcdynamics
$AGTC AGTC Reports Positive 12-Month Data from Highest Dose Groups in its Ongoing XLRP Phase 1/2 Clinical Trial https://t.co/g5hmqmLNGR
May 6th 2021, 11:05am
James__BondOO7 @James__BondOO7
RT @stock_titan: $AGTC AGTC Reports Positive 12-Month Data from Highest Dose Groups in its Ongoing XLRP Phase 1/2 Clinical Trial https://t.…
May 6th 2021, 11:05am
kevinjaybe @kevinjaybe
$AGTC Agtc Reports Positive 12-Month Data From Highest Dose Groups In Its Ongoing Xlrp Phase 1/2 Clinical Trial https://t.co/1gkZM9ScRr
May 6th 2021, 11:05am
FlashAlert_me @FlashAlert_me
$AGTC [15s. delayed]: Issued Press Release on May 06, 07:00:00: AGTC Reports Positive 12-Month Data from Highest Do… https://t.co/9hOMj1rAMv
May 6th 2021, 11:05am
stock_titan @stock_titan
$AGTC AGTC Reports Positive 12-Month Data from Highest Dose Groups in its Ongoing XLRP Phase 1/2 Clinical Trial… https://t.co/S1N2lK6ltA
May 6th 2021, 11:05am
GreenSk68859859 @GreenSk68859859
RT @AGTC_: $AGTC is excited to host a conference call to release 12-month data for its Phase 1/2 clinical trial in patients with XLRP on Ma…
May 6th 2021, 2:05am
AGTC_ @AGTC_
$AGTC is excited to host a conference call to release 12-month data for its Phase 1/2 clinical trial in patients wi… https://t.co/T8eCPQUNAv
May 6th 2021, 2:05am
TurbulentMissi1 @TurbulentMissi1
What ?!?!? $AGTC https://t.co/yStNejip16
May 5th 2021, 10:05pm
MC_OptionTrades @MC_OptionTrades
$AGTC 21-May-21 Straddle Implies a ±20.1% move. May 6 ARVO 2021 Virtual Annual Meeting https://t.co/FGtkhOajzZ
May 5th 2021, 8:05pm
blinkbarryy @blinkbarryy
@ksicrypto you should check out $AGTC great , slow but gold
May 5th 2021, 8:05pm
SwingTradeIdeas @SwingTradeIdeas
$AGTC is up 6.75% after hours on 45,417 volume. Now trading at $4.11. #AGTC #afterhoursscan
May 5th 2021, 8:05pm
TigerWTrader1 @TigerWTrader1
Somebody knows something! ???? $AGTC https://t.co/iUdJX1VVXv
May 5th 2021, 8:05pm
TheLittleDog0 @TheLittleDog0
$Agtc turn for bio squeeze???
May 5th 2021, 8:05pm
kevinjaybe @kevinjaybe
$AGTC Agtc To Host Conference Call On May 6 At 8:00 Am Et To Discuss Xlrp Full 12-Month Data From Highest Dose Grou… https://t.co/gkNYxXkS6y
May 5th 2021, 8:05pm
simplystocks_ @simplystocks_
$AGTC AGTC to Host Conference Call on May 6 at 8:00 AM ET to Discuss XLRP Full 12-Month Data from Highest Dose Grou… https://t.co/D2yJYZSPeq
May 5th 2021, 8:05pm
MSollender @MSollender
RT @BioRunUp: $AGTC AGTC to Host Conference Call on May 6 at 8:00 AM ET to Discuss XLRP Full 12-Month Data from Highest Dose Groups and 24-…
May 5th 2021, 8:05pm
BioRunUp @BioRunUp
$AGTC AGTC to Host Conference Call on May 6 at 8:00 AM ET to Discuss XLRP Full 12-Month Data from Highest Dose Grou… https://t.co/JSHZZlraYm
May 5th 2021, 8:05pm
stock_titan @stock_titan
$AGTC AGTC to Host Conference Call on May 6 at 8:00 AM ET to Discuss XLRP Full 12-Month Data from Highest Dose Grou… https://t.co/YkACU87t2l
May 5th 2021, 8:05pm
edupruni77 @edupruni77
As I said 3 days ago plus 17% $JWN. Today out buying $AGTC had recieved and aproach from EUROPEAN COMPANY. Big anno… https://t.co/w6unTD9AaO
May 5th 2021, 7:05pm
newsfilterio @newsfilterio
Editas strengthens Q1 liquidity despite rising net loss; names new chief scientific officer $EDIT $AGTC https://t.co/zW1xQWTLBV
May 5th 2021, 11:05am
glitchbotio @glitchbotio
RT @MarketCurrents: $EDIT $AGTC - Editas strengthens Q1 liquidity despite rising net loss; names new chief scientific officer https://t.co/…
May 5th 2021, 11:05am
MarketCurrents @MarketCurrents
$EDIT $AGTC - Editas strengthens Q1 liquidity despite rising net loss; names new chief scientific officer https://t.co/d3dGirP1Qp
May 5th 2021, 11:05am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2021. All rights reserved.